BC is a complex and highly heterogeneous malignant disease; approximately 20–30% of BCs have amplification and/or overexpression of the human epidermal growth factor receptor 2 (ERBB2, HER2, HER2/neu, c-erbB-2) oncogenes. The gene discussed is ERBB2; the disease is breast cancer.